Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Research Areas > Metabolic Disorder > Diabetes

Diabetes

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC9299 GRA Ex-25 Featured
GRA Ex-25 is an orally active human glucagon receptor antagonist in a transgenic murine pharmacodynamic model at 10 and 30 mpk.
More description
DC7227 PF-04620110 Featured
PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.
More description
DC10050 PF05175157 Featured
PF-05175157 is a potent and selective inhibitor of both acetyl-CoA carboxylase isoform ACC1 located primarily in liver and adipose tissue and isoform ACC2 dominant in skeletal and heart muscle, with IC50 values of 27 nM and 33 nM, respectively.
More description
DC9830 AM-2394 Featured
AM-2394 is a potent and selective Glucokinase agonist (GKA), which catalyzes the phosphorylation of glucose to glucose-6-phosphate.
More description
DC7585 Omarigliptin Featured
MK-3102 (MSD) is a novel DPP-4 Inhibitor, which improves glycaemic control with low risk of symptomatic hypoglycaemia.
More description
DC8186 Bexagliflozin3 Featured
Bexagliflozin is a potent and selective SGLT2 inhibitor with IC50 value of 5.6 μM /2 nM in SGLT1 /SGLT2 respectively.
More description
DC7515 Teglicar Featured
Teglicar, in vitro and in animal models, reduces gluconeogenesis and improves glucose homeostasis, refreshing the interest in selective and reversible L-CPT1 inhibition as a potential antihyperglycemic approach.
More description
DC8278 BVT-14225 Featured
BVT 14225 is a new selective 11b-HSD1 inhibitor, it belongs to a class of arylsulfonamidothiazoles with in vitro and in vivo antidiabetic effects
More description
DCAPI1356 Epalrestat Featured
Epalrestat is an orally active aldose reductase inhibitor that acts on diabetic neuropathy.
More description
DC6904 DAPAGLIFLOZIN Featured
Dapagliflozin, also known as BMS-512148, is a drug used to treat type 2 diabetes approved in 2012 by FDA. Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine. In clinical trials, dapagliflozin lowered HbA1c by 0.6 versus placebo percentage points when added to metformin.
More description
DC11206 HSD-016 Featured
HSD-016 (HSD016) is a potent, selective, and efficacious 11β-HSD1 inhibitor with IC50 of 149 and 530 nM for mouse and human 11β-HSD1, respectively.
More description
DC11174 ASP7657 Featured
ASP7657 (ASP-7657) is a potent, selective, orally active prostaglandin EP4 receptor antagonist with Ki values of 6.02 nM and 2.21 nM for rat and human EP4 receptors, resepctively.
More description
DC11207 INCB13739 Featured
INCB13739 (INCB-13739) is a potent, selective, oral 11βHSD1 inhibitor (IC50=1.1 nM) with high seelctivity over other dehydrogenases, glucocorticoid and mineralocorticoid receptors..
More description
DC5073 TAK-875(Fasiglifam) Featured
TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM.
More description
DC8875 Saxagliptin Featured
Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM and Ki of 1.3 nM.
More description
DC11466 PF-06409577 Featured
PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM.
More description
DC3108 PF-04971729 (Ertugliflozin) Featured
PF-04971729 is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus.
More description
DC10807 O304 Featured
O304 is a novel AMPK activator.
More description
DC12020 MK-8722 Featured
MK-8722 is a systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.
More description
DC5034 MK8245 Featured
MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.
More description
DC8041 MK-0941 Featured
MK-0941 is a novel Glucokinase activator (GKA)
More description
DC7921 Sotagliflozin (LX-4211) Featured
LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents.
More description
DC8118 GKT137831(Setanaxib) Featured
GKT137831 is a novel and specific dual Nox1/Nox4 inhibitor with Ki of 140±40 nM and 110±30 nM; a potent inhibitor of fibrosis and hepatocyte apoptosis.
More description
DC8482 CAY10415(MSDC-0160) Featured
CAY10415 is a potent, antidiabetic drug of the TZD structural class.
More description
DC3111 Canagliflozin Featured
Canagliflozin is a highly potent and selective SGLT2 inhibitor for CHO-hSGLT2, CHO-rSGLT2 and CHO-mSGLT2 with IC50 of 4.4 nM, 3.7 nM and 2 nM, respectively.
More description
DC8089 BVT 2733(BVT.2733) Featured
BVT 2733 is a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor,protecting osteoblasts against endogenous glucocorticoid induced dysfunction.
More description
DC7045 A-769662 Featured
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM, little effect on GPPase/FBPase activity.
More description
DC9690 Sinogliatin (HMS5552, RO5305552) Featured
Sinogliatin (HMS5552, RO5305552) is a mall molecule glucokinase (GCK; GK) activator.
More description
DC10581 Succinobucol(AGI 1067) Featured
Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects.
More description
DCAPI1573 Ipragliflozin (ASP1941) Featured
Ipragliflozin (ASP1941) is a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X